Attached files
| file | filename |
|---|---|
| EX-31.1 - EX-31.1 - Minerva Neurosciences, Inc. | nerv-ex311_11.htm |
| EX-32.1 - EX-32.1 - Minerva Neurosciences, Inc. | nerv-ex321_10.htm |
| EX-31.2 - EX-31.2 - Minerva Neurosciences, Inc. | nerv-ex312_8.htm |
| EX-21.1 - EX-21.1 - Minerva Neurosciences, Inc. | nerv-ex211_7.htm |
| EX-10.48 - EX-10.48 - Minerva Neurosciences, Inc. | nerv-ex1048_189.htm |
| EX-4.4 - EX-4.4 - Minerva Neurosciences, Inc. | nerv-ex44_9.htm |
| 10-K - 10-K - Minerva Neurosciences, Inc. | nerv-10k_20201231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-205764 and 333-226783 on Form S-3 and Nos. 333-242460, 333-225672, 333-223593, 333-222368, 333-216637, 333-210147, 333-203738, and 333-198753 on Form S-8 of our report dated March 8, 2021, relating to the consolidated financial statements of Minerva Neurosciences, Inc. appearing in this Annual Report on Form 10-K for the year ended December 31, 2020.
/s/ DELOITTE & TOUCHE LLP
Boston, Massachusetts
March 8, 2021